カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のジピン降圧医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Dipine Antihypertensive Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19267）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19267
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のジピン降圧医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ジピン降圧医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のジピン降圧医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ジピン降圧医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他

用途別セグメントは次のように区分されます。
・病院、診療所

世界のジピン降圧医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Johnson & Johnson、Merck & Co., Inc.、NOVARTIS、Astrazeneca、Bayer、Kyowa Hakko Kogyo、Zuventus Health care ltd、JB Chemicals and Pharmaceuticals Ltd、Boehringer Ingelheim、GSK、Daiichi-Sankyo、fujipharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ジピン降圧医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なジピン降圧医薬品メーカーの企業概要、2019年～2022年までのジピン降圧医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なジピン降圧医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ジピン降圧医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのジピン降圧医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのジピン降圧医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびジピン降圧医薬品の産業チェーンを掲載しています。
・第13、14、15章では、ジピン降圧医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ジピン降圧医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所
- 世界のジピン降圧医薬品市場規模・予測
- 世界のジピン降圧医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Johnson & Johnson、Merck & Co., Inc.、NOVARTIS、Astrazeneca、Bayer、Kyowa Hakko Kogyo、Zuventus Health care ltd、JB Chemicals and Pharmaceuticals Ltd、Boehringer Ingelheim、GSK、Daiichi-Sankyo、fujipharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他
・用途別分析2017年-2028年：病院、診療所
・ジピン降圧医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ジピン降圧医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ジピン降圧医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ジピン降圧医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ジピン降圧医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Dipine Antihypertensive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dipine Antihypertensive Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Dipine Antihypertensive Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nifedipine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dipine Antihypertensive Drugs include Johnson & Johnson, Merck & Co., Inc., NOVARTIS, Astrazeneca, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dipine Antihypertensive Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nifedipine
Amlodipine Besylate
Felidipine
Benidipine
Other
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Dipine Antihypertensive Drugs market are listed below:
Johnson & Johnson
Merck & Co., Inc.
NOVARTIS
Astrazeneca
Bayer
Kyowa Hakko Kogyo
Zuventus Health care ltd
JB Chemicals and Pharmaceuticals Ltd
Boehringer Ingelheim
GSK
Daiichi-Sankyo
fujipharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dipine Antihypertensive Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dipine Antihypertensive Drugs, with price, sales, revenue and global market share of Dipine Antihypertensive Drugs from 2019 to 2022.
Chapter 3, the Dipine Antihypertensive Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dipine Antihypertensive Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dipine Antihypertensive Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dipine Antihypertensive Drugs.
Chapter 13, 14, and 15, to describe Dipine Antihypertensive Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Dipine Antihypertensive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dipine Antihypertensive Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Nifedipine
1.2.3 Amlodipine Besylate
1.2.4 Felidipine
1.2.5 Benidipine
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Dipine Antihypertensive Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Dipine Antihypertensive Drugs Market Size & Forecast
1.4.1 Global Dipine Antihypertensive Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dipine Antihypertensive Drugs Sales in Volume (2017-2028)
1.4.3 Global Dipine Antihypertensive Drugs Price (2017-2028)
1.5 Global Dipine Antihypertensive Drugs Production Capacity Analysis
1.5.1 Global Dipine Antihypertensive Drugs Total Production Capacity (2017-2028)
1.5.2 Global Dipine Antihypertensive Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dipine Antihypertensive Drugs Market Drivers
1.6.2 Dipine Antihypertensive Drugs Market Restraints
1.6.3 Dipine Antihypertensive Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Dipine Antihypertensive Drugs Product and Services
2.1.4 Johnson & Johnson Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck & Co., Inc.
2.2.1 Merck & Co., Inc. Details
2.2.2 Merck & Co., Inc. Major Business
2.2.3 Merck & Co., Inc. Dipine Antihypertensive Drugs Product and Services
2.2.4 Merck & Co., Inc. Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 NOVARTIS
2.3.1 NOVARTIS Details
2.3.2 NOVARTIS Major Business
2.3.3 NOVARTIS Dipine Antihypertensive Drugs Product and Services
2.3.4 NOVARTIS Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Astrazeneca
2.4.1 Astrazeneca Details
2.4.2 Astrazeneca Major Business
2.4.3 Astrazeneca Dipine Antihypertensive Drugs Product and Services
2.4.4 Astrazeneca Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Dipine Antihypertensive Drugs Product and Services
2.5.4 Bayer Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kyowa Hakko Kogyo
2.6.1 Kyowa Hakko Kogyo Details
2.6.2 Kyowa Hakko Kogyo Major Business
2.6.3 Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Product and Services
2.6.4 Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zuventus Health care ltd
2.7.1 Zuventus Health care ltd Details
2.7.2 Zuventus Health care ltd Major Business
2.7.3 Zuventus Health care ltd Dipine Antihypertensive Drugs Product and Services
2.7.4 Zuventus Health care ltd Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 JB Chemicals and Pharmaceuticals Ltd
2.8.1 JB Chemicals and Pharmaceuticals Ltd Details
2.8.2 JB Chemicals and Pharmaceuticals Ltd Major Business
2.8.3 JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Product and Services
2.8.4 JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Dipine Antihypertensive Drugs Product and Services
2.9.4 Boehringer Ingelheim Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Dipine Antihypertensive Drugs Product and Services
2.10.4 GSK Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Daiichi-Sankyo
2.11.1 Daiichi-Sankyo Details
2.11.2 Daiichi-Sankyo Major Business
2.11.3 Daiichi-Sankyo Dipine Antihypertensive Drugs Product and Services
2.11.4 Daiichi-Sankyo Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 fujipharma
2.12.1 fujipharma Details
2.12.2 fujipharma Major Business
2.12.3 fujipharma Dipine Antihypertensive Drugs Product and Services
2.12.4 fujipharma Dipine Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dipine Antihypertensive Drugs Breakdown Data by Manufacturer
3.1 Global Dipine Antihypertensive Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dipine Antihypertensive Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dipine Antihypertensive Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Dipine Antihypertensive Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Dipine Antihypertensive Drugs Manufacturer Market Share in 2021
3.5 Global Dipine Antihypertensive Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dipine Antihypertensive Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dipine Antihypertensive Drugs Market Size by Region
4.1.1 Global Dipine Antihypertensive Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Dipine Antihypertensive Drugs Revenue by Region (2017-2028)
4.2 North America Dipine Antihypertensive Drugs Revenue (2017-2028)
4.3 Europe Dipine Antihypertensive Drugs Revenue (2017-2028)
4.4 Asia-Pacific Dipine Antihypertensive Drugs Revenue (2017-2028)
4.5 South America Dipine Antihypertensive Drugs Revenue (2017-2028)
4.6 Middle East and Africa Dipine Antihypertensive Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dipine Antihypertensive Drugs Sales in Volume by Type (2017-2028)
5.2 Global Dipine Antihypertensive Drugs Revenue by Type (2017-2028)
5.3 Global Dipine Antihypertensive Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dipine Antihypertensive Drugs Sales in Volume by Application (2017-2028)
6.2 Global Dipine Antihypertensive Drugs Revenue by Application (2017-2028)
6.3 Global Dipine Antihypertensive Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dipine Antihypertensive Drugs Sales by Type (2017-2028)
7.2 North America Dipine Antihypertensive Drugs Sales by Application (2017-2028)
7.3 North America Dipine Antihypertensive Drugs Market Size by Country
7.3.1 North America Dipine Antihypertensive Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Dipine Antihypertensive Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dipine Antihypertensive Drugs Sales by Type (2017-2028)
8.2 Europe Dipine Antihypertensive Drugs Sales by Application (2017-2028)
8.3 Europe Dipine Antihypertensive Drugs Market Size by Country
8.3.1 Europe Dipine Antihypertensive Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Dipine Antihypertensive Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dipine Antihypertensive Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Dipine Antihypertensive Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Dipine Antihypertensive Drugs Market Size by Region
9.3.1 Asia-Pacific Dipine Antihypertensive Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dipine Antihypertensive Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dipine Antihypertensive Drugs Sales by Type (2017-2028)
10.2 South America Dipine Antihypertensive Drugs Sales by Application (2017-2028)
10.3 South America Dipine Antihypertensive Drugs Market Size by Country
10.3.1 South America Dipine Antihypertensive Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Dipine Antihypertensive Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dipine Antihypertensive Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Dipine Antihypertensive Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Dipine Antihypertensive Drugs Market Size by Country
11.3.1 Middle East & Africa Dipine Antihypertensive Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dipine Antihypertensive Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dipine Antihypertensive Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dipine Antihypertensive Drugs
12.3 Dipine Antihypertensive Drugs Production Process
12.4 Dipine Antihypertensive Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dipine Antihypertensive Drugs Typical Distributors
13.3 Dipine Antihypertensive Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Dipine Antihypertensive Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dipine Antihypertensive Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Dipine Antihypertensive Drugs Product and Services
Table 6. Johnson & Johnson Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co., Inc. Major Business
Table 9. Merck & Co., Inc. Dipine Antihypertensive Drugs Product and Services
Table 10. Merck & Co., Inc. Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. NOVARTIS Basic Information, Manufacturing Base and Competitors
Table 12. NOVARTIS Major Business
Table 13. NOVARTIS Dipine Antihypertensive Drugs Product and Services
Table 14. NOVARTIS Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 16. Astrazeneca Major Business
Table 17. Astrazeneca Dipine Antihypertensive Drugs Product and Services
Table 18. Astrazeneca Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Dipine Antihypertensive Drugs Product and Services
Table 22. Bayer Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kyowa Hakko Kogyo Basic Information, Manufacturing Base and Competitors
Table 24. Kyowa Hakko Kogyo Major Business
Table 25. Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Product and Services
Table 26. Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zuventus Health care ltd Basic Information, Manufacturing Base and Competitors
Table 28. Zuventus Health care ltd Major Business
Table 29. Zuventus Health care ltd Dipine Antihypertensive Drugs Product and Services
Table 30. Zuventus Health care ltd Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. JB Chemicals and Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 32. JB Chemicals and Pharmaceuticals Ltd Major Business
Table 33. JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Product and Services
Table 34. JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim Dipine Antihypertensive Drugs Product and Services
Table 38. Boehringer Ingelheim Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. GSK Basic Information, Manufacturing Base and Competitors
Table 40. GSK Major Business
Table 41. GSK Dipine Antihypertensive Drugs Product and Services
Table 42. GSK Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi-Sankyo Major Business
Table 45. Daiichi-Sankyo Dipine Antihypertensive Drugs Product and Services
Table 46. Daiichi-Sankyo Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. fujipharma Basic Information, Manufacturing Base and Competitors
Table 48. fujipharma Major Business
Table 49. fujipharma Dipine Antihypertensive Drugs Product and Services
Table 50. fujipharma Dipine Antihypertensive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Dipine Antihypertensive Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Dipine Antihypertensive Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Dipine Antihypertensive Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Dipine Antihypertensive Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Dipine Antihypertensive Drugs Production Site of Key Manufacturer
Table 56. Dipine Antihypertensive Drugs New Entrant and Capacity Expansion Plans
Table 57. Dipine Antihypertensive Drugs Mergers & Acquisitions in the Past Five Years
Table 58. Global Dipine Antihypertensive Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Global Dipine Antihypertensive Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Global Dipine Antihypertensive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Dipine Antihypertensive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Dipine Antihypertensive Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Global Dipine Antihypertensive Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Global Dipine Antihypertensive Drugs Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Dipine Antihypertensive Drugs Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Dipine Antihypertensive Drugs Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Dipine Antihypertensive Drugs Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Dipine Antihypertensive Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Global Dipine Antihypertensive Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Global Dipine Antihypertensive Drugs Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Dipine Antihypertensive Drugs Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Dipine Antihypertensive Drugs Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Dipine Antihypertensive Drugs Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Dipine Antihypertensive Drugs Sales by Country (2017-2022) & (K Units)
Table 75. North America Dipine Antihypertensive Drugs Sales by Country (2023-2028) & (K Units)
Table 76. North America Dipine Antihypertensive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Dipine Antihypertensive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Dipine Antihypertensive Drugs Sales by Type (2017-2022) & (K Units)
Table 79. North America Dipine Antihypertensive Drugs Sales by Type (2023-2028) & (K Units)
Table 80. North America Dipine Antihypertensive Drugs Sales by Application (2017-2022) & (K Units)
Table 81. North America Dipine Antihypertensive Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Europe Dipine Antihypertensive Drugs Sales by Country (2017-2022) & (K Units)
Table 83. Europe Dipine Antihypertensive Drugs Sales by Country (2023-2028) & (K Units)
Table 84. Europe Dipine Antihypertensive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Dipine Antihypertensive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Dipine Antihypertensive Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Europe Dipine Antihypertensive Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Europe Dipine Antihypertensive Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Europe Dipine Antihypertensive Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Dipine Antihypertensive Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Dipine Antihypertensive Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Dipine Antihypertensive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Dipine Antihypertensive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Dipine Antihypertensive Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Dipine Antihypertensive Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Dipine Antihypertensive Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Dipine Antihypertensive Drugs Sales by Application (2023-2028) & (K Units)
Table 98. South America Dipine Antihypertensive Drugs Sales by Country (2017-2022) & (K Units)
Table 99. South America Dipine Antihypertensive Drugs Sales by Country (2023-2028) & (K Units)
Table 100. South America Dipine Antihypertensive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Dipine Antihypertensive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Dipine Antihypertensive Drugs Sales by Type (2017-2022) & (K Units)
Table 103. South America Dipine Antihypertensive Drugs Sales by Type (2023-2028) & (K Units)
Table 104. South America Dipine Antihypertensive Drugs Sales by Application (2017-2022) & (K Units)
Table 105. South America Dipine Antihypertensive Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Dipine Antihypertensive Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Dipine Antihypertensive Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Dipine Antihypertensive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Dipine Antihypertensive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Dipine Antihypertensive Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Dipine Antihypertensive Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Dipine Antihypertensive Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Dipine Antihypertensive Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Dipine Antihypertensive Drugs Raw Material
Table 115. Key Manufacturers of Dipine Antihypertensive Drugs Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Dipine Antihypertensive Drugs Typical Distributors
Table 119. Dipine Antihypertensive Drugs Typical Customers
List of Figures
Figure 1. Dipine Antihypertensive Drugs Picture
Figure 2. Global Dipine Antihypertensive Drugs Revenue Market Share by Type in 2021
Figure 3. Nifedipine
Figure 4. Amlodipine Besylate
Figure 5. Felidipine
Figure 6. Benidipine
Figure 7. Other
Figure 8. Global Dipine Antihypertensive Drugs Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Dipine Antihypertensive Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Dipine Antihypertensive Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Dipine Antihypertensive Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Dipine Antihypertensive Drugs Price (2017-2028) & (US$/Unit)
Figure 15. Global Dipine Antihypertensive Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Dipine Antihypertensive Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Dipine Antihypertensive Drugs Market Drivers
Figure 18. Dipine Antihypertensive Drugs Market Restraints
Figure 19. Dipine Antihypertensive Drugs Market Trends
Figure 20. Global Dipine Antihypertensive Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Dipine Antihypertensive Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Dipine Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Dipine Antihypertensive Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Dipine Antihypertensive Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Dipine Antihypertensive Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Dipine Antihypertensive Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Dipine Antihypertensive Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Dipine Antihypertensive Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Dipine Antihypertensive Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Dipine Antihypertensive Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Dipine Antihypertensive Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Dipine Antihypertensive Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Dipine Antihypertensive Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Dipine Antihypertensive Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Dipine Antihypertensive Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Dipine Antihypertensive Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Dipine Antihypertensive Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Dipine Antihypertensive Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Dipine Antihypertensive Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Dipine Antihypertensive Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Dipine Antihypertensive Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Dipine Antihypertensive Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Dipine Antihypertensive Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Dipine Antihypertensive Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Dipine Antihypertensive Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Dipine Antihypertensive Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Dipine Antihypertensive Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Dipine Antihypertensive Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Dipine Antihypertensive Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Dipine Antihypertensive Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Dipine Antihypertensive Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Dipine Antihypertensive Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Dipine Antihypertensive Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Dipine Antihypertensive Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Dipine Antihypertensive Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Dipine Antihypertensive Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Dipine Antihypertensive Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Dipine Antihypertensive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Dipine Antihypertensive Drugs in 2021
Figure 79. Manufacturing Process Analysis of Dipine Antihypertensive Drugs
Figure 80. Dipine Antihypertensive Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 降圧薬の世界市場 2022年-2026年
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19267 )"世界のジピン降圧医薬品市場2022年：市場規模予測（～2028年）" (英文：Global Dipine Antihypertensive Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。